Your browser doesn't support javascript.
loading
Neonatal cerebral sinovenous thrombosis: Two cases, two different gene polymorphisms and risk factors.
Turan, Özden; Anuk-Ince, Deniz; Olcay, Lale; Sezer, Taner; Gülleroglu, Kaan; Yilmaz-Çelik, Zerrin; Ecevit, Ayse.
Afiliación
  • Turan Ö; Divisions of Neonatology, Baskent University Faculty of Medicine, Ankara, Turkey.
  • Anuk-Ince D; Divisions of Neonatology, Baskent University Faculty of Medicine, Ankara, Turkey.
  • Olcay L; Divisions of Pediatric Hematology, Baskent University Faculty of Medicine, Ankara, Turkey.
  • Sezer T; Divisions of Pediatric Neurology, Baskent University Faculty of Medicine, Ankara, Turkey.
  • Gülleroglu K; Divisions of Pediatric Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey.
  • Yilmaz-Çelik Z; Department of Medical Genetics, Baskent University Faculty of Medicine, Ankara, Turkey.
  • Ecevit A; Divisions of Neonatology, Baskent University Faculty of Medicine, Ankara, Turkey.
Turk J Pediatr ; 59(1): 71-75, 2017.
Article en En | MEDLINE | ID: mdl-29168367
Turan Ö, Anuk-Ince D, Olcay L, Sezer T, Gülleroglu K, Yilmaz-Çelik Z, Ecevit A. Neonatal cerebral sinovenous thrombosis: Two cases, two different gene polymorphisms and risk factors. Turk J Pediatr 2017; 59: 71-75. Cerebral sinovenous thrombosis (CSVT) is a rare disease in the neonatal period and also the greatest risk of neonatal mortality and morbidity. In this report, we presented two cases with CSVT and different risk factors. One of these cases had methylenetetrahydrofolate reductase (MTHFR) C677T homozygous polymorphism and the other case had both MTHFR A1298C homozygous polymorphism, plasminogen activator inhibitor-1 (PAI-1) 4G/ 5G polymorphism and elevated lipoprotein a. Early diagnosis and prompt initiation of therapy of neonatal CSVT may prevent neonatal mortality and poor long-term neurodevelopmental outcomes.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis de los Senos Intracraneales / Inhibidor 1 de Activador Plasminogénico / Metilenotetrahidrofolato Reductasa (NADPH2) Tipo de estudio: Etiology_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Male / Newborn Idioma: En Revista: Turk J Pediatr Año: 2017 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis de los Senos Intracraneales / Inhibidor 1 de Activador Plasminogénico / Metilenotetrahidrofolato Reductasa (NADPH2) Tipo de estudio: Etiology_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Male / Newborn Idioma: En Revista: Turk J Pediatr Año: 2017 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía